Designation indicates entry into the U.K.’s Innovative Licensing and Access Pathway (ILAP) NEW HAVEN, Conn. and NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced that the U.K. Innovative Licensing and Access Pathway Steering Group,